ID   Anip973/NVB
AC   CVCL_W194
SY   Anip973/Navelbine
DR   Wikidata; Q54749953
RX   PubMed=17650408;
RX   PubMed=20738915;
RX   PubMed=22429577;
CC   Population: Chinese.
CC   Selected for resistance to: ChEBI; CHEBI_480999; Vinorelbine (Navelbine; NVB).
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6879 ! Anip-973
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 10
//
RX   PubMed=17650408; DOI=10.3760/j:issn:0376-2491.2007.13.016;
RA   Chen, Gong-Yan
RA   Yang, Zhao-Yang
RA   Hong, Xuan
RA   Wang, Meng
RA   Lu, Lu
RA   Zhang, Chang-Hai
RT   "Establishment of a multi drug-resistant human lung adenocarcinoma
RT   cell line and biological characteristics there of.";
RL   Zhonghua Yi Xue Za Zhi 87:924-926(2007).
//
RX   PubMed=20738915; DOI=10.3779/j.issn.1009-3419.2008.05.013;
RA   Liu, Wei
RA   Cai, Li
RA   Ning, Jin-Feng
RA   Li, Dan-Dan
RT   "Expression and significance of clusterin in Anip973/NVB cell lines.";
RL   Zhongguo Fei Ai Za Zhi 11:696-699(2008).
//
RX   PubMed=22429577; DOI=10.3779/j.issn.1009-3419.2012.03.03; PMCID=PMC5999873;
RA   Wang, Meng
RA   Hong, Xuan
RA   Sun, Qin-Wen
RA   Li, Rui-Lin
RA   Yang, Zhao-Yang
RA   Chen, Gong-Yan
RT   "Establishment of animal model of a human lung adenocarcinoma
RT   drug-resistant cell line Anip973/NVB and investigation on mechanism of
RT   drug resistance.";
RL   Zhongguo Fei Ai Za Zhi 15:146-151(2012).
//